Neutrophil-mediated type IV collagen degradation is elevated in patients with mild endoscopic ulcerative colitis reflecting early mucosal destruction.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
18 Jan 2024
18 Jan 2024
Historique:
received:
28
08
2023
accepted:
16
01
2024
medline:
19
1
2024
pubmed:
19
1
2024
entrez:
18
1
2024
Statut:
epublish
Résumé
Neutrophils play a significant role in sustaining chronic inflammation in Inflammatory Bowel Disease. The intestinal basement membrane acts as a barrier for immunological homeostasis, where the α3 and α4 chains of type IV collagen are expressed on the mucosal surface. We wanted to develop a biomarker reflecting early tissue injury, providing an opportunity for intervention. Two competitive enzyme-linked immunosorbent assays (ELISAs) quantifying human neutrophil elastase (HNE) degraded neo-epitopes of COL4A3 and COL4A4 were developed and investigated in two observational cohorts (n = 161, n = 100). A biomarker of MMP-mediated degradation of COL4A1 (C4M) was used for comparison. In Cohort 1, patients with mild endoscopic ulcerative colitis showed elevated levels of C4A3-HNE compared to those with severe disease. C4M had a strong positive correlation with disease activity. C4A3-HNE/C4M provided superior discrimination between mild and severe endoscopic disease and negatively correlated to disease activity. In Cohort 2, C4A4-HNE and C4A4-HNE/C4M showed similar trends. C4A3-HNE and C4A4-HNE possibly reflect early intestinal tissue injury. Combining the markers with a biomarker of another α-chain of the same collagen provides information on two distinct stages of mucosal damage. These biomarkers may be used to monitor disease flare-up in patients in remission, reducing the need for frequent endoscopic procedures.
Identifiants
pubmed: 38238446
doi: 10.1038/s41598-024-52208-y
pii: 10.1038/s41598-024-52208-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1641Informations de copyright
© 2024. The Author(s).
Références
McDowell, C., Farooq, U. & Haseeb, M. Inflammatory Bowel Disease. 2022. http://www.ncbi.nlm.nih.gov/pubmed/30137275 .
McGuckin, M. A., Eri, R., Simms, L. A., Florin, T. H. J. & Radford-Smith, G. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm. Bowel Dis. 15, 100–113. https://doi.org/10.1002/ibd.20539 (2009).
doi: 10.1002/ibd.20539
pubmed: 18623167
Antoni, L., Nuding, S., Wehkamp, J. & Stange, E. F. Intestinal barrier in inflammatory bowel disease. World J. Gastroenterol. 20, 1165–1179. https://doi.org/10.3748/wjg.v20.i5.1165 (2014).
doi: 10.3748/wjg.v20.i5.1165
pubmed: 24574793
pmcid: 3921501
Vogelsang, H. Do changes in intestinal permeability predict disease relapse in Crohn’s disease?. Inflamm. Bowel Dis. 14(Suppl 2), 162–163. https://doi.org/10.1097/00054725-200810001-00077 (2008).
doi: 10.1097/00054725-200810001-00077
D’Inca, R. et al. Can permeability to sugars predict relapses in Crohn’s disease?. Gut 34, S50–S73 (1993).
Turpin, W. et al. Increased intestinal permeability is associated with later development of Crohn’s disease. Gastroenterology. 159, 2092–2100. https://doi.org/10.1053/j.gastro.2020.08.005 (2020).
doi: 10.1053/j.gastro.2020.08.005
pubmed: 32791132
Drury, B., Hardisty, G., Gray, R. D. & Ho, G. Neutrophil extracellular traps in inflammatory bowel disease: Pathogenic mechanisms and clinical translation. Cell. Mol. Gastroenterol. Hepatol. 12, 321–333. https://doi.org/10.1016/j.jcmgh.2021.03.002 (2021).
doi: 10.1016/j.jcmgh.2021.03.002
pubmed: 33689803
pmcid: 8166923
Zhou, G. X. & Liu, Z. J. Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease. J. Dig. Dis. 18, 495–503. https://doi.org/10.1111/1751-2980.12540 (2017).
doi: 10.1111/1751-2980.12540
pubmed: 28857501
Fischbach, W. et al. Leucocyte elastase in chronic inflammatory bowel diseases: A marker of inflammatory activity?. Digestion 37, 88–95. https://doi.org/10.1159/000199473 (1987).
doi: 10.1159/000199473
pubmed: 3650181
Kirov, S. et al. Degradation of the extracellular matrix is part of the pathology of ulcerative colitis. Mol. Omics J. 15, 67–76. https://doi.org/10.1039/c8mo00239h (2019).
doi: 10.1039/c8mo00239h
Jorch, S. K. & Kubes, P. An emerging role for neutrophil extracellular traps in noninfectious disease. Nat. Med. 23, 279–287. https://doi.org/10.1038/nm.4294 (2017).
doi: 10.1038/nm.4294
pubmed: 28267716
Mortensen, J. H. et al. The intestinal tissue homeostasis–the role of extracellular matrix remodeling in inflammatory bowel disease. Expert Rev. Gastroenterol. Hepatol. 13, 977–993. https://doi.org/10.1080/17474124.2019.1673729 (2019).
doi: 10.1080/17474124.2019.1673729
pubmed: 31587588
Bächinger, H. P., Mizuno, K., Vranka, J. A. & Boudko, S. P. Collagen Formation and Structure. in Comprehensive Natural Products II, 469–530 (Elsevier, 2010). https://doi.org/10.1016/B978-008045382-8.00698-5 .
Oka, Y. et al. Distribution of collagen type IV α1-6 chains in human normal colorectum and colorectal cancer demonstrated by immunofluorescence staining using chain-specific epitope-defined monoclonal antibodies. J. Gastroenterol. Hepatol. 17, 980–986. https://doi.org/10.1046/j.1440-1746.2002.02789.x (2002).
doi: 10.1046/j.1440-1746.2002.02789.x
pubmed: 12167119
Sato, H. et al. The differential distribution of type IV collagen α chains in the subepithelial basement membrane of the human alimentary canal. Arch. Histol. Cytol. 70, 313–323. https://doi.org/10.1679/aohc.70.313 (2007).
doi: 10.1679/aohc.70.313
pubmed: 18431032
Maillet, N. Rapid peptides generator: Fast and efficient in silico protein digestion. NAR Genom. Bioinform. 2, 004. https://doi.org/10.1093/nargab/lqz004 (2020).
doi: 10.1093/nargab/lqz004
Gefter, M. L., Margulies, D. H. & Scharff, M. D. A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet. 3, 231–236. https://doi.org/10.1007/BF01551818 (1977).
doi: 10.1007/BF01551818
pubmed: 605383
Sand, J. M. et al. MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis—Validation of two novel biomarker assays. PLoS One 8, 1–12. https://doi.org/10.1371/journal.pone.0084934 (2013).
doi: 10.1371/journal.pone.0084934
Domislovic, V. et al. Inflammatory biomarkers of extracellular matrix remodeling and disease activity in Crohn’s disease and ulcerative colitis. J. Clin. Med. https://doi.org/10.3390/jcm11195907 (2022).
doi: 10.3390/jcm11195907
pubmed: 36233775
pmcid: 9572110
Katsanos, A. H. et al. Biomarker Development in Chronic Inflammatory Diseases. In Biomarkers for Endometriosis: State of the Art (ed. D’Hooghe, T.) 41–75 (Springer, 2017). https://doi.org/10.1007/978-3-319-59856-7_3 .
doi: 10.1007/978-3-319-59856-7_3
Lindholm, M. et al. Extracellular matrix fragments of the basement membrane and the interstitial matrix are serological markers of intestinal tissue remodeling and disease activity in dextran sulfate sodium colitis. Dig. Dis. Sci. 64, 3134–3142. https://doi.org/10.1007/s10620-019-05676-6 (2019).
doi: 10.1007/s10620-019-05676-6
pubmed: 31123972
van Haaften, W. T. et al. Serological biomarkers of tissue turnover identify responders to anti-TNF therapy in crohn’s disease: A pilot study. Clin. Transl. Gastroenterol. 11, e00217. https://doi.org/10.14309/ctg.0000000000000217 (2020).
doi: 10.14309/ctg.0000000000000217
pubmed: 33094957
pmcid: 7494148
Alexdottir, M. S. et al. Serological biomarkers of extracellular matrix turnover and neutrophil activity are associated with long-term use of vedolizumab in patients with Crohn’s disease. Int. J. Mol. Sci. https://doi.org/10.3390/ijms23158137 (2022).
doi: 10.3390/ijms23158137
pubmed: 35897710
pmcid: 9329899
Mortensen, J. et al. P235 serological biomarkers of interstitial matrix and basement membrane remodelling correlate the modified mayo endoscopic score (mMES) for ulcerative colitis. J. Crohns Colitis 14, S260–S261. https://doi.org/10.1093/ecco-jcc/jjz203.364 (2020).
doi: 10.1093/ecco-jcc/jjz203.364
Mortensen, J. et al. P318 Protein FingerPrint assays reflecting neutrophil activity, mucosal damage, and tissue fibrosis are surrogate biomarkers for mucosal healing in pediatric Crohn’s disease. J. Crohns Colitis 17, i458–i459. https://doi.org/10.1093/ecco-jcc/jjac190.0448 (2023).
doi: 10.1093/ecco-jcc/jjac190.0448
Nakano, T. & Scott, P. G. Purification and characterization of a gelatinase produced by fibroblasts from human gingiva. Biochem. Cell Biol. 64, 387–393. https://doi.org/10.1139/o86-054 (1986).
doi: 10.1139/o86-054
pubmed: 3013248
E. Arthur Z., S. Susanta K., Neuman, K. C. & G. Gregory I. Matrix Metallopeptidase 9/Gelatinase B. in Handbook of Proteolytic Enzymes. 1, 754–763 (2013). https://doi.org/10.1016/B978-0-12-382219-2.00157-5 .
Mei, K. et al. The role of intestinal immune cells and matrix metalloproteinases in inflammatory bowel disease. Front. Immunol. 13, 1–15. https://doi.org/10.3389/fimmu.2022.1067950 (2023).
doi: 10.3389/fimmu.2022.1067950
Nusrat, A., Parkos, C. A., Liang, T. W., Carnes, D. K. & Madara, J. L. Neutrophil migration across model intestinal epithelia: Monolayer disruption and subsequent events in epithelial repair. Gastroenterology 113, 1489–1500. https://doi.org/10.1053/gast.1997.v113.pm9352851 (1997).
doi: 10.1053/gast.1997.v113.pm9352851
pubmed: 9352851
Spinelli, A. et al. ECCO guidelines on therapeutics in ulcerative colitis: Medical treatment. J. Crohns Colitis 16, 179–189. https://doi.org/10.1093/ecco-jcc/jjab177 (2022).
doi: 10.1093/ecco-jcc/jjab177
pubmed: 34635910